RAFAEL HOLDINGS, INC. Warrant, Exercise Price, Decrease
RAFAEL HOLDINGS, INC. (RFL) reported Warrant, Exercise Price, Decrease of $22.91 per share for the 3-month period ending 2024-10-31, per its 10-Q filed 2024-12-11.
Financial Statements › Notes › Equity › Stockholders' Equity Note
us-gaap:WarrantExercisePriceDecrease · last filed 2024-12-20
- RAFAEL HOLDINGS, INC. warrant, exercise price, decrease for the quarter ending 2024-10-31 was $22.91, a 0.00% change year-over-year.
- RAFAEL HOLDINGS, INC. warrant, exercise price, decrease for the quarter ending 2023-10-31 was $22.91.
- RAFAEL HOLDINGS, INC. warrant, exercise price, decrease for fiscal 2024 was $22.91, a 0.00% change from fiscal 2023.
- RAFAEL HOLDINGS, INC. warrant, exercise price, decrease for fiscal 2023 was $22.91.
| Period end | Warrant, Exercise Price, Decrease 3 month | Warrant, Exercise Price, Decrease 9 month | Warrant, Exercise Price, Decrease 12 month | Warrant, Exercise Price, Decrease 18 month |
|---|---|---|---|---|
| 2024-10-31 | $22.91 10-Q · filed 2024-12-11 | |||
| 2024-07-31 | $22.91 10-K/A · filed 2024-12-20 | |||
| 2024-04-30 | $22.91 10-Q · filed 2024-06-14 | |||
| 2023-10-31 | $22.91 10-Q · filed 2023-12-14 | |||
| 2023-07-31 | $22.91 10-K · filed 2023-10-30 | |||
| 2022-06-06 | $22.91 10-Q · filed 2024-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |